• GDC-0994: Reading ERK Signals Across Models

  2026-09-01

  GDC-0994 is a selective ERK1/2 inhibitor for connecting pathway engagement with cancer-cell phenotypes and cholestatic liver injury. This article translates mechanistic evidence into model-specific assay decisions rather than repeating a conventional workflow guide.

• CHIR-99021 and Axonogenesis: An Assay-Design Guide

  2026-09-01

  CHIR-99021 and CT99021 offer precise GSK-3 control for stem cell and neuronal studies. This guide connects pathway activation with the time-resolved RNA, protein, and imaging assays needed to interpret axon formation without confusing transcriptional induction with functional protein accumulation.

• HotStart Universal 2X Green qPCR Master Mix Guide

  2026-08-31

  Build a reproducible dye-based qPCR workflow for FGFR2 fusion research, from RNA quality control and primer design through melt curve confirmation. This practical guide shows how hot-start Taq polymerase, Green I fluorescence, and ROX normalization can support gene expression quantification in cholangiocarcinoma models while highlighting assay limits and troubleshooting decisions.

• Vemurafenib Workflows for Melanoma Resistance

  2026-08-31

  Vemurafenib (PLX4032) provides a controlled way to interrogate BRAF V600E signaling, melanoma cell proliferation inhibition, and adaptive drug resistance. This research workflow connects dose-response assays with phospho-signaling and multi-omics designs, helping distinguish true pathway dependence from paradoxical RAF activation.

• Phosbind Acrylamide: Workflow and Troubleshooting

  2026-08-30

  Phosbind Acrylamide enables phosphate-dependent mobility shifts in SDS-PAGE, offering an antibody-sparing route to compare phosphorylated and non-phosphorylated proteins. This practical workflow connects the reagent to SepM–ComDE signaling research while emphasizing controls, gel preparation, and troubleshooting limits.

• DiscoveryProbe Natural Product Library Plus Workflow

  2026-08-29

  Turn a diverse natural product library into a disciplined path from primary enzyme inhibition to cell-based validation. This workflow uses the DiscoveryProbe™ Natural Product Library Plus to support reproducible HTS, orthogonal confirmation, and mechanism-aware hit triage for challenging targets such as Cryptosporidium parvum AdhE.

• Bifendate (DDB): Liver Assay Workflows

  2026-08-28

  Bifendate (DDB) combines hepatoprotection research with mechanistic control of lysosomal autophagy and lipid-droplet accumulation. This practical guide translates the reference study into cell-based workflows, animal-study planning, assay controls, and troubleshooting strategies.

• ERK5, Vitamin D, and Myeloid Leukemia Differentiation

  2026-08-28

  The reference study separates the roles of ERK5 and ERK1/2 in 1α,25-(OH)2 vitamin D3-induced differentiation of AML cell lines. Its key contribution is showing that ERK5 inhibition changes differentiation-marker patterns while also producing cell-cycle arrest, particularly in G2, providing a mechanistic basis for combining vitamin D derivatives with ERK5-directed strategies.

• SB 431542 for TGF-β EndMT Studies

  2026-08-27

  Use SB 431542 as a selective ALK5 inhibitor to test whether TGF-β receptor activity drives PM2.5-induced endothelial–mesenchymal transition. This workflow combines Smad phosphorylation, endothelial and mesenchymal markers, lncRNA analysis, migration, and proliferation readouts for stronger mechanistic conclusions.

• Estramustine Compliance in Very High-Risk Prostate Cancer

  2026-08-27

  This prospective study found that reduced estramustine phosphate exposure during six-month neoadjuvant chemohormonal therapy with degarelix acetate was associated with inferior biochemical recurrence-free survival in very high-risk prostate cancer. Its main contribution is to identify treatment compliance, alongside disease-risk category, as a clinically informative factor while highlighting substantial toxicity and the limits of causal interpretation.

• Fingolimod (FTY720) and Immune Trafficking

  2026-08-26

  Fingolimod (FTY720) offers translational researchers a controllable way to study S1P-regulated lymphocyte trafficking, CNS signaling, and the design constraints of emerging in vivo CAR-T-mimicking platforms.

• Y-27632 Dihydrochloride: ROCK Inhibitor Workflows

  2026-08-26

  Y-27632 dihydrochloride provides a selective way to interrogate ROCK1/2-dependent cytoskeletal tension, survival, and invasion phenotypes. This practical guide connects dose-finding, stem-cell handling, 3D models, and translational assay design while distinguishing established product data from workflow recommendations.

• Maraviroc (UK-427857) Experimental Workflows

  2026-08-25

  Maraviroc enables controlled CCR5 perturbation across HIV-1 entry inhibition, HIV tropism studies, and exploratory neuroinflammation modulation. This practical guide connects nanomolar pharmacology with time-resolved ischemic-stroke assays, emphasizing solvent control, matched vehicle experiments, and interpretation limits.

• DAF-2 diacetate for Soybean Nodule NO Imaging

  2026-08-25

  DAF-2 diacetate converts sulfur-dependent reactive nitrogen species biology into a spatial, live-cell fluorescence readout for soybean nodule research. This workflow guide covers probe handling, reference-aligned experimental design, controls, imaging optimization, and limits for broader nitric oxide studies.

• Masitinib (AB1010): KIT/PDGFR Workflow Guide

  2026-08-24

  Masitinib (AB1010) provides a DMSO-compatible approach for selective KIT, PDGFRα, and PDGFRβ inhibition in cancer biology, mast cell, and inflammatory research. It is not appropriate for aqueous or ethanol-based protocols, and its dossier-level activity should not be treated as evidence for broad kinase inhibition or a clinical treatment recommendation.

8625 records 1/575 page Next 12345 下5页 Last page